H. Li

发表

Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancer

W. Cliby, J. Villeneuve, M. Silverman, 1999, Genes, chromosomes & cancer.

Bronchial carcinoid tumors: importance of prognostic factors that influence patterns of recurrence and overall survival.

H. Li, C. Deschamps, J. Bonner, 1998, Radiology.

Prognostic significance of the tumor-stroma ratio in gallbladder cancer.

H. Li, Y. Zhang, S. Yuan, 2017, Neoplasma.

Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis.

M. J. Webb, H. Li, G. Keeney, 2000, Gynecologic oncology.

Meta-analysis of clodronate and breast cancer survival

H. Li, T. Ha, 2018 .

Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes

H. Burstein, H. Li, M. Hassett, 2020, Breast Cancer Research and Treatment.

Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study.

T. Eberlein, H. Li, P. Goedegebuure, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Meta-analysis of clodronate and breast cancer survival

H. Li, Huihua Li, T. Ha, 2007, British Journal of Cancer.

Tyrosine kinase inhibitors significantly improved survival outcomes in patients with metastatic gastrointestinal stromal tumour: a multi-institutional cohort study.

C. McGahan, H. Li, C. Simmons, 2020, Current oncology.

Radical Resection or Chemoradiotherapy for Cervical Esophageal

H. Li, S. Chou, R. H. Lee, 2010 .

Does the time from diagnostic biopsy to neoadjuvant chemotherapy affect the rate of pathologic complete response in stages I-III breast cancer?

S. Chia, H. Li, C. Simmons, 2020, Current oncology.

Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons.

M. Tang, G. Pfeifer, S. Amin, 2000, Journal of the National Cancer Institute.

Distant metastasis in triple-negative breast cancer.

S. C. Chen, M. Hou, H. Li, 2013, Neoplasma.

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

L. Rorke, J. Wisoff, S. Shurin, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Model-Based Meta-Analysis for Quantifying Paclitaxel Dose Response in Cancer Patients

H. Li, A. Joshi, D. Lu, 2014, CPT: pharmacometrics & systems pharmacology.

Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.

J. Katzmann, H. Li, G. Keeney, 1999, Gynecologic oncology.

Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma.

H. Li, C. Deschamps, J. Bonner, 1999, The Annals of thoracic surgery.

Patients with stage I non-small cell lung carcinoma at postoperative risk for local recurrence, distant metastasis, and death: implications related to the design of clinical trials.

H. Li, C. Deschamps, J. Bonner, 1999, International journal of radiation oncology, biology, physics.

Patterns of failure and overall survival in patients with completely resected T3 N0 M0 non-small cell lung cancer.

H. Li, C. Deschamps, J. Bonner, 1999, International journal of radiation oncology, biology, physics.

Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analyses of recurrence risks.

P. Pairolero, H. Li, V. Trastek, 1997, The Annals of thoracic surgery.

The effect of M-stage on patterns of failure in posterior fossa primitive neuroectodermal tumors treated on CCG-921: a phase III study in a high-risk patient population.

M. Mehta, L. Rorke, H. Li, 1997, International journal of radiation oncology, biology, physics.

Evolving Practice Patterns Over Two Decades (1993-2013) in the Management of Desmoid-type Fibromatosis in British Columbia.

P. Munk, H. Li, P. Truong, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

R. Salunga, M. Erlander, D. Sgroi, 2011, British Journal of Cancer.

Predictors of subclinical nodal involvement in clinical stages I and II non-small cell lung cancer: implications in the inoperable and three-dimensional dose-escalation settings.

H. Li, Y. Garces, J. Bonner, 1999, International journal of radiation oncology, biology, physics.

Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma.

P. Roche, M. Silverman, H. Li, 2000, Gynecologic oncology.

Neoadjuvant Therapy for Breast Cancer: Updates and Proceedings From the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer

K. Gelmon, F. Lu, H. Li, 2018, Current Oncology.

The role of the genomic breast cancer index in predicting pathologic complete response in breast cancer patients treated with neoadjuvant anthracycline plus taxane.

M. Erlander, M. Mathieu, F. André, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term survival among Hodgkin's lymphoma patients with gastrointestinal cancer: a population-based study.

M. Stovall, L. Constine, H. Li, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.